.
ZYME financial statements
* Numbers in thousands
| Capitalization * | 349 204 |
|---|---|
| EV * | 583 539 |
| Number of shares * | 51 657 |
| EPS | -4,10 |
| Revenue * | 26 680 |
| Net income * | -211 843 |
| Operating profit * | -215 633 |
| Total liabilities * | 140 038 |
| Net debt * | 33 543 |
| Total assets * | 389 132 |
| Equity * | 249 094 |
| Cash and investments * | 50 741 |
.
ZYME valuation
| P/E | -2,08 |
|---|---|
| P/B | 1,77 |
| P/S | 16,49 |
| E/P | -48 |
| P/FCF | -2 147,85 |
.
ZYME profitability
| ROE | -85% |
|---|---|
| ROA% | -55% |
| ROIC% | -68% |